The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences
Drugs & drug processes
Tick (check) box to add article to PDF "basket"
An EU-funded project is developing infrastructure to support innovation and accelerate the development of new vaccines. This will enhance European competitiveness in this field and bring major societal benefits.
Published: 20 December 2018
An EU-funded project has developed a technique to design and synthesise highly stable proteins. The approach enables proteins to be made from scratch, tailored to carry out specific tasks for advances in fields such as biomedicine and biotech - boosting Europe's competitiveness.
Published: 14 December 2018
Advanced imaging technologies are revolutionising biological and biomedical science. An EU-funded project enabled researchers worldwide to better access cutting-edge biological and medical imaging technologies, to accelerate the great societal benefits this technological revolution will provide.
Published: 12 December 2018
An EU-funded project is using synthetic biology techniques to design broad-spectra vaccines against mycoplasmas and viral infections in farm animals. By designing a growth medium without animal components and developing a platform to engineer new vaccines, the project will give the EU livestock industry a much-needed boost.
Published: 21 November 2018
Type 1 diabetes develops in childhood, requiring constant - often painful - management from the start. EU-funded researchers are testing an artificial pancreas that could transform the quality of life of youngsters suffering from the disease.
Published: 14 November 2018
Most vaccines need to be kept cool during transport and storage, but this can be hard to accomplish. EU-funded researchers keen to tackle this healthcare challenge have developed heat-tolerant and even needle-free formulations of an HIV-1 vaccine candidate. They expect their processes to work for many other vaccines as well.
Published: 30 October 2018
Microfluidic bioreactors allow chemical reactions to take place on a very small scale, saving time, money and materials. An EU-funded project has developed microfluidic bioreactor technologies that could lead to a wide range of applications, including innovative medicines.
Published: 24 August 2018
An EU-funded project developed a simple, affordable and effective vaccine strategy to prevent the incidence of both hepatitis C virus and HIV-1. This could significantly increase the life expectancy of people receiving antiretroviral therapy for HIV-1.
Published: 27 July 2018
Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer - but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.
Published: 6 July 2018
EU-funded researchers have analysed the efficacy and required dosage of several antibiotics licensed decades ago. Their findings could enable doctors to prescribe certain drugs with greater confidence and strengthen EU efforts to tackle the growing problem of drug resistance.
Published: 25 June 2018